Suvretta Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-316,000
| Closed | -$2.12M | – | 100 |
|
|
2024
Q1 | $2.12M | Sell |
316,000
-3,394,539
| -91% | -$22.8M | 0.08% | 72 |
|
|
2023
Q4 | $21.8M | Buy |
3,710,539
+657,239
| +22% | +$3.86M | 0.99% | 32 |
|
|
2023
Q3 | $29.8M | Buy |
3,053,300
+833,607
| +38% | +$8.13M | 1.61% | 20 |
|
|
2023
Q2 | $26.3M | Buy |
2,219,693
+400,000
| +22% | +$4.74M | 1.41% | 25 |
|
|
2023
Q1 | $19.6M | Buy |
1,819,693
+8,297
| +0.5% | +$89.5K | 0.83% | 38 |
|
|
2022
Q4 | $20.9M | Sell |
1,811,396
-51,204
| -3% | -$592K | 0.88% | 39 |
|
|
2022
Q3 | $27.8M | Buy |
1,862,600
+1,262,600
| +210% | +$18.8M | 1.15% | 34 |
|
|
2022
Q2 | $5.41M | Buy |
+600,000
| New | +$5.41M | 0.21% | 63 |
|